Soligenix Future Growth
Future criteria checks 2/6
Soligenix's earnings are forecast to decline at 11% per annum while its annual revenue is expected to grow at 27.1% per year. EPS is expected to grow by 57.3% per annum.
Key information
-11.0%
Earnings growth rate
57.3%
EPS growth rate
| Biotechs earnings growth | 34.8% |
| Revenue growth rate | 27.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1 | -9 | N/A | N/A | 2 |
| 12/31/2025 | 1 | -9 | N/A | N/A | 2 |
| 12/31/2024 | 1 | -8 | N/A | N/A | 2 |
| 6/30/2024 | 0 | -7 | -8 | -8 | N/A |
| 3/31/2024 | 1 | -7 | -8 | -8 | N/A |
| 12/31/2023 | 1 | -6 | -9 | -9 | N/A |
| 9/30/2023 | 1 | -8 | -10 | -10 | N/A |
| 6/30/2023 | 1 | -10 | -11 | -11 | N/A |
| 3/31/2023 | 1 | -10 | -12 | -12 | N/A |
| 12/31/2022 | 1 | -14 | -13 | -13 | N/A |
| 9/30/2022 | 1 | -15 | -12 | -12 | N/A |
| 6/30/2022 | 1 | -15 | -12 | -12 | N/A |
| 3/31/2022 | 1 | -15 | -11 | -11 | N/A |
| 12/31/2021 | 1 | -13 | -12 | -12 | N/A |
| 9/30/2021 | 1 | -13 | -13 | -13 | N/A |
| 6/30/2021 | 1 | -12 | -13 | -13 | N/A |
| 3/31/2021 | 2 | -12 | -13 | -13 | N/A |
| 12/31/2020 | 2 | -18 | -11 | -11 | N/A |
| 9/30/2020 | 3 | -15 | -10 | -10 | N/A |
| 6/30/2020 | 3 | -16 | -9 | -9 | N/A |
| 3/31/2020 | 4 | -15 | -8 | -8 | N/A |
| 12/31/2019 | 5 | -9 | -8 | -8 | N/A |
| 9/30/2019 | 5 | -10 | -8 | -8 | N/A |
| 6/30/2019 | 5 | -9 | -6 | -6 | N/A |
| 3/31/2019 | 5 | -8 | -8 | -8 | N/A |
| 12/31/2018 | 5 | -9 | -7 | -7 | N/A |
| 9/30/2018 | 6 | -8 | -7 | -7 | N/A |
| 6/30/2018 | 6 | -7 | -7 | -7 | N/A |
| 3/31/2018 | 5 | -8 | N/A | -6 | N/A |
| 12/31/2017 | 5 | -7 | N/A | -7 | N/A |
| 9/30/2017 | 6 | -5 | N/A | -6 | N/A |
| 6/30/2017 | 7 | -6 | N/A | -6 | N/A |
| 3/31/2017 | 9 | -4 | N/A | -6 | N/A |
| 12/31/2016 | 10 | -3 | N/A | -5 | N/A |
| 9/30/2016 | 12 | -5 | N/A | -5 | N/A |
| 6/30/2016 | 13 | -1 | N/A | -4 | N/A |
| 3/31/2016 | 11 | -4 | N/A | -5 | N/A |
| 12/31/2015 | 9 | -8 | N/A | -5 | N/A |
| 9/30/2015 | 8 | -4 | N/A | -4 | N/A |
| 6/30/2015 | 7 | -11 | N/A | -5 | N/A |
| 3/31/2015 | 7 | -8 | N/A | -4 | N/A |
| 12/31/2014 | 7 | -7 | N/A | -2 | N/A |
| 9/30/2014 | 6 | -8 | N/A | -3 | N/A |
| 6/30/2014 | 4 | -10 | N/A | -4 | N/A |
| 3/31/2014 | 3 | -12 | N/A | -4 | N/A |
| 12/31/2013 | 3 | -10 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DOA0 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DOA0 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DOA0 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DOA0's revenue (27.1% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: DOA0's revenue (27.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DOA0's Return on Equity is forecast to be high in 3 years time